expired vaccine used; I  experienced chills vomiting, nausea and an itchy red bump at the injection site; .I  experienced chills vomiting, nausea and an itchy red bump at the injection site; .I  experienced chills vomiting, nausea and an itchy red bump at the injection site; I experienced chills vomiting, nausea and an itchy red bump at the injection site; I experienced chills vomiting, nausea and an itchy red bump at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (I  experienced chills vomiting, nausea and an itchy red bump at the injection site), VOMITING (.I  experienced chills vomiting, nausea and an itchy red bump at the injection site), NAUSEA (.I  experienced chills vomiting, nausea and an itchy red bump at the injection site), INJECTION SITE PRURITUS (I experienced chills vomiting, nausea and an itchy red bump at the injection site) and INJECTION SITE ERYTHEMA (I experienced chills vomiting, nausea and an itchy red bump at the injection site) in a 64-year-old male patient who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch nos. 050E21A, 012A21A and 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (COVID 19 Vaccine Moderna) (unknown route) dosage was changed to 1 dosage form. On 19-Oct-2021, received third dose of mRNA-1273 (COVID 19 Vaccine Moderna) (unknown route) dosage was changed to 1 dosage form. In October 2021, the patient experienced CHILLS (I  experienced chills vomiting, nausea and an itchy red bump at the injection site), VOMITING (.I  experienced chills vomiting, nausea and an itchy red bump at the injection site), NAUSEA (.I  experienced chills vomiting, nausea and an itchy red bump at the injection site), INJECTION SITE PRURITUS (I experienced chills vomiting, nausea and an itchy red bump at the injection site) and INJECTION SITE ERYTHEMA (I experienced chills vomiting, nausea and an itchy red bump at the injection site). On 19-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On 19-Oct-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved. At the time of the report, CHILLS (I  experienced chills vomiting, nausea and an itchy red bump at the injection site), VOMITING (.I  experienced chills vomiting, nausea and an itchy red bump at the injection site), NAUSEA (.I  experienced chills vomiting, nausea and an itchy red bump at the injection site), INJECTION SITE PRURITUS (I experienced chills vomiting, nausea and an itchy red bump at the injection site) and INJECTION SITE ERYTHEMA (I experienced chills vomiting, nausea and an itchy red bump at the injection site) had resolved.        For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided.  This is a case of expired vaccine used and concerns a 64 year-old male patient with no reported medical history who experienced the unexpected non-serious events of chills, nausea, vomiting, injection site pruritis and injection site erythema. The event of expired vaccine used occurred on the same day as the third dose, booster of Moderna COVID-19 Vaccine, and the remaining events occurred on an unknown date. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.; Sender's Comments: This is a case of expired vaccine used and concerns a 64 year-old male patient with no reported medical history who experienced the unexpected non-serious events of chills, nausea, vomiting, injection site pruritis and injection site erythema. The event of expired vaccine used occurred on the same day as the third dose, booster of Moderna COVID-19 Vaccine, and the remaining events occurred on an unknown date. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.